Moreover, in cancer cells, PHD3 has been shown to increase activity of ACC2, which converts acetyl-CoA → malonyl-CoA, the latter suppressing carnitine palmitoyltransferase I (CPT1), the rate-limiting step in fatty acid oxidation (24, 44). Here, EGLN3 is linked to cancer.